文献速递牙周病

补体C3作为牙周炎潜在药物靶点:顺式孟德尔随机化证据

Complement C3 as a potential drug target in periodontitis: Evidence from the cis-Mendelian randomization approach.
PubMed 文献 · J Clin Periodontol · 2023-11-05

该研究采用药物靶点孟德尔随机化方法,利用C3基因座附近的三个顺式工具变量,在17,353例牙周炎患者和28,210例欧洲对照中评估遗传预测的C3抑制对牙周炎风险的影响。

要点

  • 遗传预测的C3抑制与牙周炎风险降低相关(OR 0.91每1个标准差降低)。
  • 该发现支持C3作为牙周炎潜在药物靶点,需进一步临床验证。

核心结论

  • 遗传预测的C3抑制可能降低牙周炎风险,提示C3阻断对牙周炎有潜在保护作用。

研究设计与样本

  • 药物靶点孟德尔随机化研究,工具变量选自C3编码基因座(染色体19:6,677,715-6,730,573,GRCh37/hg19)。
  • 从5,368名欧洲裔个体的GWAS中选取三个与血清C3水平相关的独立SNP(rs141552034、rs145406915、rs11569479,P<1×10-4)。
  • 结局数据来自17,353例临床牙周炎病例和28,210例欧洲对照的GWAS。
  • 采用Wald比值和逆方差加权荟萃分析估计OR值。

临床怎么用

  • 提示C3抑制可能作为牙周炎辅助治疗策略,但尚需临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Evidence from a Phase IIa trial showed that a complement C3-targeted drug reduced gingival inflammation in patients with gingivitis. Using drug-target Mendelian randomization (MR), we investigated whether genetically proxied C3 inhibition alters the risk of periodontitis. MATERIALS AND METHODS: We used multiple 'cis' instruments from the vicinity of the encoding loci of C3. Instrument selection was restricted to the drug target encoding loci (chromosome 19; 6,677,715-6,730,573 (GRCh37/hg19)). We selected three uncorrelated single-nucleotide polymorphisms (rs141552034, rs145406915, rs11569479) that were associated with serum C3 levels (p value <1 × 10-4 ) from a genome-wide association study (GWAS) of 5368 European descent individuals. We extracted association statistics from a GWAS of 17,353 clinical periodontitis cases and 28,210 European controls. Wald ratios were combined using inverse-variance weighted meta-analysis to estimate the odds ratio (OR) of the genetically proxied inhibition of C3 in relation to periodontitis. RESULTS: MR analysis revealed that the inhibition of C3 reduces the odds of periodontitis (OR 0.91 per 1 standard deviation reduction in C3; 95% confidence interval 0.87-0.96, p value = .0003). CONCLUSIONS: Findings from our MR analysis suggest a potential protective effect of C3 blockade against periodontitis.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Alayash Z, Baumeister SE, Holtfreter B, et al. Complement C3 as a potential drug target in periodontitis: Evidence from the cis-Mendelian randomization approach. J Clin Periodontol. 2023. PMID: 37926509. doi:10.1111/jcpe.13894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。